Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Research and Application of an AI Agent-Based MBBS Course Assistant

Prior to the quasi-experiment, this study performed semi-structured interviews among Bachelor of Medicine and Bachelor of Surgery(MBBS) undergraduate students from the Belt and Road International Medical College, Zhejiang University. Based on learning science, cognitive load theory and causal inference frameworks, the interview outline focused on system usability, feedback quality, learning reasoning processes, cognitive burden and instructional optimization advice. Each 20-30 minute individual interview was audio-recorded with participants' informed consent and verbatim transcribed for standardized qualitative analysis.

The quasi-experiment recruited no fewer than 60 MBBS students. The sample size was determined by intergroup statistical power analysis to guarantee around 30 participants per group for valid intergroup comparison. All eligible students were randomly assigned into two groups with balanced demographic and academic baseline characteristics. The experimental group (n=30) received structured epidemiological learning assisted by the (Socratic Agent for Guided Epidemiology) SAGE (Artificial Intelligence)AI agent with professional Socratic cognitive guidance. The control group (n=30) adopted general large language model (LLM)-based learning without systematic thinking intervention. Participants with clinically diagnosed severe mental disorders, cognitive dysfunction or inability to finish the complete research process were excluded. A baseline epidemiological knowledge pre-test confirmed no significant academic differences between the two groups via independent samples t-test, and all participants had no prior experience of AI-assisted medical learning.

The semi-structured interviews were conducted to collect students' authentic learning experiences, interactive perceptions and cognitive characteristics during the use of SAGE agent and general LLMs, providing qualitative evidence for the iterative optimization of AI teaching tools. All interviewees completed baseline assessments and preliminary AI learning trials, ensuring qualified professional foundation and genuine interactive experience. Conducted by trained researchers, the standardized interviews centered on three core themes: system usability and feedback clarity; AI-induced changes in information extraction, hypothesis formulation and causal inference; and common learning barriers including interactive obstacles, comprehension difficulties, cognitive overload and potential AI over-reliance. Transcribed interview data were analyzed through thematic analysis to summarize typical user experience patterns. Qualitative outcomes were triangulated with quantitative experimental results to revise the SAGE teaching protocol, optimize agent prompt chains and improve the interpretation of experimental findings.

The quasi-experiment consisted of three standardized stages. In the pre-test stage, all participants signed informed consent, completed a 25-item clinical epidemiology knowledge scale, an 11-item reasoning ability test and a demographic questionnaire to establish consistent baseline levels. In the intervention stage, the experimental group received standardized training in confounder identification and causal inference construction in strict accordance with the SAGE teaching protocol. The SAGE agent improved students' advanced epidemiological reasoning ability through continuous multi-round Socratic questioning and targeted cognitive guidance. The control group received equal-duration learning in the same experimental environment, only using conventional search engines and unguided LLMs for basic information retrieval without any cognitive and thinking intervention. All participants submitted screenshots to record their accurate AI tool usage duration after completing learning tasks.

In the post-test stage, all participants finished parallel-version epidemiological knowledge assessments and unified reasoning ability tests. Validated scales were adopted to evaluate students' cognitive load, system usability, learning satisfaction and academic self-confidence. Students' final scores of the Epidemiology course were collected as supplementary indicators of long-term learning effectiveness. Upon the completion of data collection, backend AI interaction logs were summarized and strictly screened. Invalid samples with insufficient interaction rounds or incomplete responses were excluded to ensure high data quality and reliable experimental conclusions.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Estimé)

60

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

    • Zhejiang
      • Yiwu, Zhejiang, Chine, 322000
        • Recrutement
        • Zhejiang University International School of Medicine
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant
  • Adulte

Accepte les volontaires sains

Oui

La description

Inclusion Criteria:

  • 1: The undergraduate students of the "Belt and Road Initiative" International Medical School of Zhejiang University who have officially registered for the MBBS program
  • 2: Voluntary signing of the informed consent form

Exclusion Criteria:

  • 1: Having severe mental illnesses (such as severe depression, bipolar disorder, acute phase of schizophrenia), serious physical diseases or cognitive impairments
  • 2: Is currently participating in other studies that may affect the outcome indicators of this research
  • 3: Have systematically studied or participated in research that is highly similar to this study
  • 4: No experience of AI agent learning

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Science basique
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Intervention group
Socratic Agent for Guided Epidemiology
A total of 30 participants are assigned to the experimental group receiving the SAGE teaching model, namely the Socratic Agent for Guided Epidemiology.
Comparateur actif: Control group
General LLM
30 participants are allocated to the control group with teaching assistance from a general large language model (General LLM).

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Clinical Epidemiology Knowledge Assessment Scale (Utrecht questionnaire on knowledge on clinical epidemiology for evidence-based practice)
Délai: Before the intervention (One to seven days before starting the epidemiology course) and After the intervention(Within half a month after completing the epidemiology course)
The test consists of 19 multiple-choice questions and 2 calculation questions, each worth 1 point. There are also 4 essay questions, each worth 3 points. The total score is 33 points. The higher the score, the better the mastery of clinical epidemiology knowledge.
Before the intervention (One to seven days before starting the epidemiology course) and After the intervention(Within half a month after completing the epidemiology course)
Epidemiological Reasoning Test
Délai: Before the intervention (One to seven days before starting the epidemiology course ) and After the intervention(Within half a month after completing the epidemiology course)
This section consists of eleven questions and is designed to test students' epidemiological reasoning skills. Scores range from 0 to 11, with higher scores indicating higher levels of epidemiological reasoning ability.
Before the intervention (One to seven days before starting the epidemiology course ) and After the intervention(Within half a month after completing the epidemiology course)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
System Usability Scale(SUS)
Délai: Immediately after intervention(One to seven days after completing the epidemiology course)
It consists of 10 items and is scored using the Likert scale (1 = strongly disagree, 5 = strongly agree). The total score is converted to a range of 0-100 to evaluate the overall usability of the system. Additionally, based on a standardized scoring system, the SUS score is assigned letter grades, ranging from "F" (0-60 points) to "A" (91-100 points).
Immediately after intervention(One to seven days after completing the epidemiology course)
Needs and perceptions questionnaire (AI-powered simulation-based teaching agent)
Délai: Qualitative research stage (one to five months before starting the epidemiology course
This questionnaire employs the 5-point Likert scale (ranging from 1 to 5), with a total score range of 18 to 90. The higher the score, the greater the subject's acceptance of the AI-assisted teaching system, the effectiveness of teaching support, and the evaluation of its application value.
Qualitative research stage (one to five months before starting the epidemiology course
Student's final exam score in the Epidemiology course
Délai: Immediately after intervention(One to seven days after completing the epidemiology course)
The score ranges from 0 to 100 points. A score of 60 or above is considered passing.
Immediately after intervention(One to seven days after completing the epidemiology course)
Demographic information questionnaire
Délai: Before the intervention (One to seven days before starting the epidemiology course)
The title of this section is used to analyze demographic data, and it mainly includes Name,Tel,Birthday,Gender,Grade,Country,GPA or credit grade,Monthly Disposable income,your father's education level,your mother's education level, Previous AI Experience.
Before the intervention (One to seven days before starting the epidemiology course)
Learning Satisfaction and Self-confidence Scale
Délai: Immediately after intervention(One to seven days after completing the epidemiology course)
Participants rated each item using a Likert-type response scale indicating their level of agreement with the statements (1 = strongly disagree to 5 = strongly agree). the total score ranges from 13 to 65.Higher scores indicated greater satisfaction with the learning experience and higher perceived self-confidence in learning.
Immediately after intervention(One to seven days after completing the epidemiology course)
Cognitive Load Scale
Délai: After the intervention(Within half a month after completing the epidemiology course)
The 10 items are scored on a scale of 0 ("completely not") to 10 ("completely"), with higher scores indicating greater cognitive load. Total score ranges from 0 to 100 points.
After the intervention(Within half a month after completing the epidemiology course)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

15 mai 2026

Achèvement primaire (Estimé)

31 janvier 2027

Achèvement de l'étude (Estimé)

31 janvier 2027

Dates d'inscription aux études

Première soumission

13 juillet 2026

Première soumission répondant aux critères de contrôle qualité

3 août 2026

Première publication (Réel)

7 août 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

7 août 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

3 août 2026

Dernière vérification

1 août 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • KY-2025-374

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner